Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1149 of 6351
-
Can hospitals manufacture their own stem cells? a french trial aims to find out
Knowledge-focused Not yet recruitingThe objective of the study is to establish the first French hospital-based Good Manufacturing Practice (GMP)-compliant platform for the production of clinical-grade induced pluripotent stem cells (iPSCs) for future regenerative medicine applications. The primary objective is to …
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Could early treatment tame a painful skin condition?
Disease control Not yet recruitingThe aim of this study is to evaluate the effectiveness of early treatment with secukinumab in patients with moderate-to-severe hidradenitis suppurativa (HS) and assess its impact on disease progression using data from multiple European data sources. All data will be sourced from …
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Which eye implant best tames glaucoma? a head-to-head trial aims to find out.
Disease control Not yet recruitingThe Baerveldt Versus Paul (BvP) Study is a Registry-based Randomised Controlled Trial, Comparing the Baerveldt Glaucoma Implant (BGI) and the Paul Glaucoma Implant (PGI). Participants will Include patients requiring aqueous shunt surgery for control of intraocular pressure and gl…
Phase 4 • Sponsor: University of Sydney • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Neck surgery may help clear Alzheimer's toxins from the brain
Disease control Not yet recruitingAlzheimer's disease (AD) is a severe neurodegenerative disease with heavy social burden. Current drugs cannot reverse disease progression. Brain glymphatic system and meningeal lymphatic dysfunction lead to impaired clearance of Aβ and Tau protein, which is an important pathogene…
Sponsor: Southwest Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Brain training plus social coaching may help older adults with schizophrenia live better
Disease control Not yet recruitingThis randomized controlled clinical trial will test a blended intervention that combines Executive Function Training with Cognitive-Behavioral Skills Training (E-CBSST). E-CBSST will be delivered to adults with late-life schizophrenia to determine if it increases Cognitive Behavi…
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Wearable device aims to unfreeze gait in Parkinson's
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if the cueStim device can reduce the duration of freezing of gait (FoG) that occurs in patients with Parkinson's Disease. The study will compare two modes of operation of the cueStim device; both modes of operation use the same wearable…
Sponsor: Fortis Medical Devices Limited • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Ventilator breathing workout may help ICU patients breathe on their own faster
Disease control Not yet recruitingMechanical ventilation causes rapid diaphragm muscle atrophy, detectable within 18 hours of ventilator support, which is a major contributor to weaning failure and prolonged ICU stay. This randomized controlled trial tests whether a physiotherapist-guided inspiratory endurance t…
Sponsor: University of Santiago de Compostela • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Daily vitamin pills may sharpen teen minds and strengthen bones, large trial tests
Disease control Not yet recruitingMEDHA is a randomized controlled trial among 10-18 year old girls to examine the use-case of the United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP) multiple micronutrient supplement (MMS) formulation and to test an enhanced regimen (MMS+) with add…
Phase 3 • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New brain scan could spot tumors more accurately than MRI
Diagnosis Not yet recruitingThis Phase II clinical trial, sponsored by \*\*Primo Biotechnology Co., Ltd.\*\*, evaluates the clinical benefit of \*\*$\^{18}$F-FET PET/CT\*\* in diagnosing glioma. The study aims to compare the diagnostic performance of $\^{18}$F-FET PET imaging against traditional brain MRI, …
Phase 3 • Sponsor: Primo Biotechnology Co., Ltd • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
Blood test could spare thousands from invasive TB diagnosis
Diagnosis Not yet recruitingTuberculosis (TB) remains a major global health challenge, affecting over 10 million people annually. Hong Kong carries an intermediate TB burden, with \~3,200 new cases reported yearly. Pulmonary TB (PTB), the most common form, presents diagnostic difficulties. Traditional metho…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Nasal spray could offer rapid relief for debilitating cluster headaches
Symptom relief Not yet recruitingThe purpose of this study is to assess headache response rate for minimal pain at 30 minutes following zavegepant administration and to assess additional effectiveness and treatment failure endpoints at various timepoints after zavegepant administration
Phase 2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Can High-Flow oxygen through a tracheostomy speed ventilator weaning?
Disease control Not yet recruitingMulticentre randomized trial to determine whether tracheal high-flow nasal oxygen can improve weaning outcome vs. conventional oxygen therapy in critically ill tracheostomized patients who are hypoxemic.
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a smartphone app help smokers quit for good?
Disease control Not yet recruitingAs part of post-marketing clinical monitoring and with a view to applying for the digital medical device Quitoxil® to be included on the LPPR list, this prospective, multicentre, controlled, randomised clinical trial aims to evaluate the clinical impact of support provided by Qui…
Sponsor: KLAVA Innovation • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a simple MRI and blood test catch pancreatic cancer earlier?
Diagnosis Not yet recruitingPancreatic ductal adenocarcinoma (PDAC) is diagnosed at an advanced, incurable stage in more than 80% of cases in Switzerland. Certain warning signs - new-onset diabetes, unexplained weight loss, or a family history of pancreatic cancer - may indicate elevated risk, but are not s…
Sponsor: Saskia Hendrich • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
Blood-flow cuffs may mimic exercise to ease Parkinson's symptoms
Symptom relief Not yet recruitingIschemic conditioning (IC) is a promising therapy that can mimic the physiological effects of physical exercise. IC consists of using a cuff to measure blood pressure and calibrate 200 mmHg on the upper or lower limb. Thus, at alternating intervals of 5 minutes, ischemia or reper…
Sponsor: Hospital Israelita Albert Einstein • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Antibiotics vs. placebo for Kids' sinus infections: which works best?
Disease control Not yet recruitingThis study is being conducted at multiple hospitals and clinics to better understand whether antibiotics truly help children feel better when they have a sinus infection (acute sinusitis). Children in the study are randomly assigned (like flipping a coin) to receive either amoxic…
Phase 4 • Sponsor: Nader Shaikh • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Gut bacteria may shield nerves from chemo damage – a trial puts it to the test
Symptom relief Not yet recruitingThe pbjective of this study is to assess the impact of a multi-strain bacteria probiotic OXXYSLAB® on the reduction of oxaliplatin-induced peripheral neuropathy in patients with stage III colon cancer receiving FOLFOX or XELOX regimen in adjuvant treatment, assessed using the oxa…
Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Oral drug elraglusib aims to tame advanced solid tumors
Disease control Not yet recruitingThis study is being done to test the safety of elraglusib when taken once a day and to assess: * How the body processes the drug (pharmacokinetics) * Assess potential effects of the drug on heart rhythm * Find the highest daily dose that can be given without causing side effects
Phase 1/2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Smart sensors could help Parkinson's patients spend less time 'Off'
Symptom relief Not yet recruitingAlthough numerous tools have been developed in recent years with the enhancement of new technologies precision and the reduction of their size, still few medical devices are used in clinical routine in Parkinson's Disease. Knowledge about Parkinson's Disease motor symptoms has be…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
No-Surgery weight loss: new stitch procedure tested in 186 people
Disease control Not yet recruitingThis is a multi-center, open-label, 2-group randomized pivotal study evaluating a minimally invasive weight loss procedure. The intent is to evaluate the safety and effectiveness of POSE2.0 (sutures placed in the mid + distal body without placement in the fundus), with a moderate…
Sponsor: USGI Medical • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC